Marie® may soon become the first FDA-cleared upright particle therapy solution, aiming to reshape radiotherapy delivery across the U.S....
The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....
Marking its first investment in Asia and the cardiovascular gene therapy space, Angelini Ventures backs Singapore-based Nuevocor to drive clinical development of NVC-001 for LMNA DCM....
Magnetom Flow RT Pro Edition enables adaptive radiotherapy with AI-powered imaging, helium-independent cooling, and simplified installation near linear accelerators for enhanced patient care....
New QA system aims to enhance geometric accuracy in MR-guided radiation therapy and stereotactic planning ...
Modular end-to-end solution showcased at ESCMID 2025 promises to transform lab automation and eliminate pre-treatment bottlenecks...
Introduced at the Indonesian Women Imaging Society event, the new mammography system delivers rapid 50° tomosynthesis for greater diagnostic clarity, enabling earlier detection and improved outcomes for women nationwide....
Adoption of Sectra's enterprise imaging solution aims to streamline workflows and boost collaboration in oncology diagnostics....
Advancing the Future of At-Home Kidney Diagnostics ...
Fragmentomics pioneer showcases DELFI-TF treatment monitoring solution alongside early detection capabilities at a premier oncology research event ...